William Tse, M.D. Associate Professor Director, AML/MDS Program and BMT-Hematologic Malignancies Translational Research Program Education: Sun Yat-Sen University School of Medicine, P.R. China – 1986 University of Colorado Denver School of Medicine Division of Medical Oncology Tel: 303-724-2372 Fax: 303-724-3889

Bio
Dr. William Tse joined the University of Colorado Cancer Center in March 2008 as the Director of Clinical Myelodysplastic Syndrome Program and the Director of BMT-Hematologic Malignancies Translational Research Program. He received training in Clinical Pathology at North Shore University Hospital, NYU School of Medicine; Internal Medicine at Long Island Jewish Medical Center, Albert Einstein College of Medicine; and Medical Oncology at Fred Hutchinson Cancer Research Center/University of Washington School of Medicine. Then he was recruited as Assistant Professor of Medicine at Case Western Reserve University School of Medicine, where he worked from 2004-2008

Research
Dr. Tse focuses on clinical and laboratory translational research of hematopoietic malignancies. His laboratory research is focused on leukemia biology, gene-gene collaborative leukemogenesis, leukemia stem cell signaling, prognostic biomarkers, and leukemic mouse models. His clinical research interest is focused on developing novel anti-leukemic drugs and experimental therapeutics for hematopoietic malignancies. Dr. Tse is the principle investigator on numerous national and local therapeutic clinical trials.